CreoSG Co.,Ltd. Share Price

Equities

A040350

KR7040350001

Software

End-of-day quote Korea S.E. 03:30:00 30/04/2024 am IST 5-day change 1st Jan Change
835 KRW -0.60% Intraday chart for CreoSG Co.,Ltd. +30.67% +61.82%

Financials

Sales 2022 9.78B 7.11M 593M Sales 2023 9.76B 7.09M 592M Capitalization 64.8B 47.11M 3.93B
Net income 2022 -10.44B -7.59M -633M Net income 2023 -11.74B -8.54M -713M EV / Sales 2022 10.9 x
Net Debt 2022 22.59B 16.43M 1.37B Net Debt 2023 2.54B 1.85M 154M EV / Sales 2023 6.9 x
P/E ratio 2022
-8.01 x
P/E ratio 2023
-5.54 x
Employees 33
Yield 2022 *
-
Yield 2023
-
Free-Float 67.41%
More Fundamentals * Assessed data
Dynamic Chart
CUROCOM Co., Ltd. announced that it has received KRW 8.5 billion in funding from CUROHOLDINGS Co., Ltd. CI
CUROCOM Co., Ltd. announced that it expects to receive KRW 8.5 billion in funding from CUROHOLDINGS Co., Ltd. and other investor CI
CUROCOM Co., Ltd.(KOSDAQ:A040350) dropped from S&P Global BMI Index CI
CUROCOM Co., Ltd. announced that it has received KRW 6 billion in funding CI
KIB Private Equity Co., Ltd, KIB CURO Second Acquisition Purpose Company completed the acquisition of a 37.359021% stake in Curo Co.,Ltd. from CUROCOM Co., Ltd., GNCO Co., Ltd., Q Capital Partners Co., Ltd., Qyuro F & B Co., Ltd. and Dongjun Kim CI
CUROCOM Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
KIB Private Equity Co., Ltd, KIB CURO Second Acquisition Purpose Company agreed to acquire a 37.359021% stake in Curo Co.,Ltd. from CUROCOM Co., Ltd., GNCO Co., Ltd., Q Capital Partners Co., Ltd., Qyuro F & B Co., Ltd. and Dongjun Kim for KRW 51.9 billion. CI
CUROCOM Co., Ltd. announced that it has received KRW 6 billion in funding CI
CUROCOM Co., Ltd. announced that it expects to receive KRW 6 billion in funding CI
CUROCOM Co., Ltd. announced that it has received KRW 8.399998653 billion in funding from Curo Holdings Co., Ltd., Q Capital Partners Co., Ltd. CI
CUROCOM Co., Ltd. announced that it expects to receive KRW 8.399998653 billion in funding from Curo Holdings Co., Ltd., Q Capital Partners Co., Ltd. CI
Sumagen Co., Ltd. announced that it has received KRW 11.864430381 billion in funding from CUROCOM Co., Ltd. CI
Sumagen Co., Ltd. announced that it expects to receive KRW 11.864430381 billion in funding from CUROCOM Co., Ltd. CI
CUROCOM Co.,Ltd. announced that it has received KRW 3 billion in funding CI
Qyuro F & B Co., Ltd. announced that it has received KRW 5.4 billion in funding from CUROCOM Co., Ltd. and other investors CI
More news
1 day-0.60%
1 week+30.67%
Current month+83.52%
1 month+83.52%
3 months+74.69%
6 months+71.81%
Current year+61.82%
More quotes
1 week
661.00
Extreme 661
855.00
1 month
405.00
Extreme 405
855.00
Current year
405.00
Extreme 405
855.00
1 year
405.00
Extreme 405
855.00
3 years
405.00
Extreme 405
2 020.00
5 years
405.00
Extreme 405
3 180.00
10 years
405.00
Extreme 405
5 400.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 30/04/30
Comptroller/Controller/Auditor 50 25/10/25
Members of the board TitleAgeSince
Director/Board Member 54 24/15/24
Chief Executive Officer 54 30/04/30
Director/Board Member 64 -
More insiders
Date Price Change Volume
02/24/02 964 +15.45% 5,387,206
30/24/30 835 -0.60% 1,417,549
29/24/29 840 +8.11% 4,184,214
26/24/26 777 +11.16% 4,666,049
25/24/25 699 -9.22% 3,531,907

End-of-day quote Korea S.E., April 30, 2024

More quotes
CUROCOM Co.,Ltd. is a Korea-based company mainly engaged in the solution business and the distribution business. The Company operates its business under two main divisions: solution business division and distribution division. Its solution business division engages in the development of software, such as bank automation and network control systems (BANCSs), which are integrated solutions used to manage core banking data such as deposits and withdrawals, and provision of maintenance services. Its distribution division distributes computers, computer peripherals and other communication products, such as thin film transistors (TFT) light emitting diode (LED) monitors and others. The Company also develops acquired immune deficiency syndrome (AIDS) vaccines and pharmaceuticals, operates coffee chain shops, and distributes coffee under the brand name illy and coffee machines.
More about the company
  1. Stock Market
  2. Equities
  3. A040350 Stock